{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:25:06Z","timestamp":1785039906416,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.intimp.2008.04.002","type":"journal-article","created":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T17:20:42Z","timestamp":1210958442000},"page":"1172-1182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC\/Nga mice by suppressing macrophage migration inhibitory factor"],"prefix":"10.1016","volume":"8","author":[{"given":"Sun Up","family":"Noh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ah","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2008.04.002_bib1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jaad.2004.12.044","article-title":"Green tea and the skin","author":"Hsu","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2008.04.002_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00403-003-0402-y","article-title":"Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNF\u03b1","volume":"295","author":"Trompezinski","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.intimp.2008.04.002_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00403-005-0540-5","article-title":"Protective effects of (\u2212)-epicatechin-3-gallate on UVA-induced damage in HaCaT keratinocytes","volume":"296","author":"Huang","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.intimp.2008.04.002_bib4","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1038\/sj.onc.1207035","article-title":"Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice","volume":"22","author":"Afaq","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2008.04.002_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1600-0625.2007.00585.x","article-title":"Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse model","volume":"16","author":"Hsu","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.intimp.2008.04.002_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1189\/jlb.69.5.719","article-title":"Green tea polyphenol (\u2212)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress","volume":"69","author":"Katiyar","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2008.04.002_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2008.04.002_bib8","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.jaad.2005.04.034","article-title":"Atopic dermatitis","volume":"53","author":"Abramovits","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2008.04.002_bib9","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1016\/j.jaci.2005.10.018","article-title":"10. Atopic dermatitis","volume":"117","author":"Boguniewicz","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.all.0000182544.37724.b5","article-title":"Suggestions regarding a more appropriate understanding of atopic dermatitis","volume":"5","author":"Beltrani","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000083893","article-title":"Recent highlights in the pathophysiology of atopic eczema","volume":"136","author":"Allam","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2230.2005.01980.x","article-title":"The pathophysiology of atopic eczema","volume":"31","author":"Allam","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.intimp.2008.04.002_bib13","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.jaad.2005.04.060","article-title":"The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis","volume":"53","author":"Novak","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2008.04.002_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/bbrc.1997.7633","article-title":"Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis","volume":"240","author":"Shimizu","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2008.04.002_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jdermsci.2004.08.007","article-title":"Role of macrophage migration inhibitory factor (MIF) in the skin","volume":"37","author":"Shimizu","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.intimp.2008.04.002_bib16","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00003246-200201001-00004","article-title":"Macrophage migration inhibitory factor","volume":"30","author":"Baugh","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.intimp.2008.04.002_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni720","article-title":"Development of chronic colitis is dependent on the cytokine MIF","volume":"2","author":"de Jong","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib18","first-page":"2691","article-title":"The presence of macrophage migration inhibitory factor in human trabecular meshwork and its upregulatory effects on the T helper 1 cytokine","volume":"43","author":"Takase","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.intimp.2008.04.002_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/cc4899","article-title":"Macrophage migration inhibitory factor: controller of systemic inflammation","volume":"10","author":"Larson","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.intimp.2008.04.002_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2008.04.002_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1445-5994.2005.00853.x","article-title":"New therapeutic target in inflammatory disease: macrophage migration inhibitory factor","volume":"35","author":"Morand","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.intimp.2008.04.002_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-5793(97)01261-1","article-title":"The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase","volume":"417","author":"Rosengren","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.intimp.2008.04.002_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.intimp.2004.12.017","article-title":"Plant-derived anti-inflammatory compounds affect MIF tautomerase activity","volume":"5","author":"Molnar","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2008.04.002_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/intimm\/9.3.461","article-title":"Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC\/Nga mice","volume":"9","author":"Matsuda","year":"1997","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2004.02.013","article-title":"Animal models for atopic dermatitis: are they relevant to human disease?","volume":"36","author":"Shiohara","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.intimp.2008.04.002_bib26","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.intimp.2006.06.011","article-title":"Induction of atopic eczema\/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC\/Nga mice","volume":"6","author":"Kang","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2008.04.002_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(00)00498-5","article-title":"Dermal toxicity of topical (\u2212)epigallocatechin-3-gallate in BALB\/c and SKH1 mice","volume":"158","author":"Stratton","year":"2000","journal-title":"Cancer Lett"},{"key":"10.1016\/j.intimp.2008.04.002_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.jid.5700603","article-title":"Topical application with a new NF-kappaB inhibitor improves atopic dermatitis in NC\/NgaTnd mice","volume":"127","author":"Tanaka","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2008.04.002_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0002-9440(10)61238-2","article-title":"Tissue regeneration using macrophage migration inhibitory factor-impregnated gelatin microbeads in cutaneous wounds","volume":"167","author":"Zhao","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.intimp.2008.04.002_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000076128","article-title":"Topical application of FK506 (tacrolimus) ointment inhibits mite antigen-induced dermatitis by local action in NC\/Nga mice","volume":"133","author":"Sasakawa","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0091-6749(99)70339-8","article-title":"Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis","volume":"104","author":"Shimizu","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib32","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","article-title":"An essential regulatory role for macrophage migration inhibitory factor in T-cell activation","volume":"93","author":"Bacher","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2008.04.002_bib33","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74","volume":"197","author":"Leng","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2008.04.002_bib34","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2008.04.002_bib35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cyto.2006.09.006","article-title":"Macrophage migration inhibitory factor in zinc-allergic systemic contact dermatitis","volume":"35","author":"Yanagi","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2008.04.002_bib37","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/eji.200323751","article-title":"Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice","volume":"33","author":"Shimizu","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2133.1999.03206.x","article-title":"Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease","volume":"141","author":"Steinhoff","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2008.04.002_bib39","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1046\/j.0022-202x.2001.01366.x","article-title":"High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis","volume":"116","author":"Shimizu","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2008.04.002_bib40","doi-asserted-by":"crossref","first-page":"14410","DOI":"10.1073\/pnas.0507189102","article-title":"Role for macrophage migration inhibitory factor in asthma","volume":"102","author":"Mizue","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2008.04.002_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cyto.2005.04.002","article-title":"Macrophage migration inhibitory factor (MIF) contributes to the development of allergic rhinitis","volume":"31","author":"Nakamaru","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2008.04.002_bib42","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.4049\/jimmunol.177.9.5779","article-title":"Cutting edge: deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses","volume":"177","author":"Wang","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2008.04.002_bib43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1210\/me.2007-0065","article-title":"The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity","volume":"21","author":"Flaster","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.intimp.2008.04.002_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)63797-2","article-title":"Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo","volume":"162","author":"Fingerle-Rowson","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.intimp.2008.04.002_bib45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2174\/1381612023394674","article-title":"Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors","volume":"8","author":"Orita","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.intimp.2008.04.002_bib46","doi-asserted-by":"crossref","first-page":"24976","DOI":"10.1074\/jbc.M203220200","article-title":"The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents","volume":"277","author":"Lubetsky","year":"2002","journal-title":"J Biol Chem"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908001161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908001161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:01:33Z","timestamp":1747242093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576908001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1567576908001161"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2008.04.002","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC\/Nga mice by suppressing macrophage migration inhibitory factor","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2008.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}